Research

Melissa L. Rayhill, MD, clinical assistant professor of neurology, highlighted the many advancements being made to help people suffering from migraine headaches in an editorial she co-authored that was published in June in the Journal of the American Medical Association.

Research by M. Laura Feltri, MD, that seeks to design and develop a therapy for multiple sclerosis (MS) — leveraging a novel drug target discovered by Feltri’s team — has received a $250,000 investment from the Empire Discovery Institute (EDI).

Forty-eight oral and poster presentations were showcased at the 14th annual Buffalo Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

A pair of research studies led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, reveal important new findings as to how regeneration of myelin in multiple sclerosis (MS) fails and, potentially, more efficient ways to treat it.

Students and laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the seventh annual GGB Research Day.

Four students in the MD-PhD Program have received prestigious fellowships from the National Institutes of Health (NIH) in 2020.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have published a paper that is helping to define the best time to give a specific treatment to infants born with Krabbe disease (KD). 

Jacobs School of Medicine and Biomedical Sciences researchers Richard W. Browne, PhD, and Robert Zivadinov, MD, PhD, are investigators for a $957,000 grant from the U.S. Army Medical Research and Development Command to explore the progression of neurodegeneration in multiple sclerosis (MS).